CN105418516B - A kind of quinazoline compounds and preparation method thereof - Google Patents

A kind of quinazoline compounds and preparation method thereof Download PDF

Info

Publication number
CN105418516B
CN105418516B CN201510957056.0A CN201510957056A CN105418516B CN 105418516 B CN105418516 B CN 105418516B CN 201510957056 A CN201510957056 A CN 201510957056A CN 105418516 B CN105418516 B CN 105418516B
Authority
CN
China
Prior art keywords
aryl
alkyl
quinazoline compounds
substituted aryl
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201510957056.0A
Other languages
Chinese (zh)
Other versions
CN105418516A (en
Inventor
唐林
唐文斌
谭美容
杨禛
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xinyang Normal University
Original Assignee
Xinyang Normal University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xinyang Normal University filed Critical Xinyang Normal University
Priority to CN201510957056.0A priority Critical patent/CN105418516B/en
Publication of CN105418516A publication Critical patent/CN105418516A/en
Application granted granted Critical
Publication of CN105418516B publication Critical patent/CN105418516B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/74Quinazolines; Hydrogenated quinazolines with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to ring carbon atoms of the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention discloses a kind of quinazoline compounds, concrete structure formula is:Wherein, R1For aryl, substituted aryl or alkyl;R2For fluorine, chlorine or methyl;R3For aryl, substituted aryl or alkyl.Using amino acid and o-nitroacetophenone compound as the raw material reacted, in recyclable palladium carbon(Pd/C)Under catalytic action, by agitating and heating in a solvent, there can be compatibility well to water and air, you can obtain quinazoline compounds.This method need not add any oxidant, reducing agent, part and alkalinity additive, and reaction condition is gentle, it is easy to accomplish large-scale production.Test result indicates that the yield of the quinazoline compounds of acquisition may be up to 92%.

Description

A kind of quinazoline compounds and preparation method thereof
Technical field
The present invention relates to the field of chemical synthesis, specially a kind of quinazoline compounds and preparation method thereof.
Background technology
Quinazoline compounds are largely present in nature, including large biological molecule, drug molecule and natural products In, it is a kind of most important organic compound type.Quinazoline compounds are widely used, can be used as agricultural chemicals, spices, with And the bioactive molecule such as intermediate, synthetic protein of medicine and the monomer of functional material(J. Med. Chem., 2004, 47, 871; J. Med. Chem., 2006, 49, 6015).
Due to the importance of quinazoline compound, therefore by region of chemistry and living nature and the widely pass of medical field Note.But regrettably, traditional method is exactly to pass through oxygen in the presence of strong oxidizer by o-aminoacetophenone and benzylamine etc. Change condensation can with a step formed quinoline compound (Chem. Commun., 2010, 46, 5244; Chem. Commun., 2011, 47, 7818–7820;Angew. Chem. Int. Ed. 2012, 51, 8077–8081).These methods will be used To some excess of oxidant, such as TBHP, these oxidants easily explode, to being brought in actual production process Some unsafe factors.The problem of simultaneously maximum is that the prepared product out of these methods is often confined to 2- aryl quinoline azoles Quinoline, just it cannot get for the quinazoline of 2 fat substitutions.Therefore the prospect of its application is leveraged.
Therefore, existing quinazoline compounds and preparation method thereof are improved, greatly improve its application field, have been one Individual urgent problem.
The content of the invention
In order to overcome above-mentioned deficiency of the prior art, the invention provides one kind with amino acid and ortho-nitroacetophenone class Initiation material of the compound as reaction, it is easy to accomplish quinazoline compounds of large-scale production and preparation method thereof.Reaction Mild condition, can be compatible with water and air, it is not necessary to adds any oxidant, reducing agent, part and alkalescence and adds Add agent, it is only necessary in a solvent agitating and heating can high productivity obtain various substituted quinazoline compounds.
The object of the present invention is achieved like this:
A kind of quinazoline compounds, its concrete structure formula are:
Wherein, R1For aryl, substituted aryl, alkyl;R2For fluorine, chlorine, methyl;R3For aryl, substituted aryl, alkyl.
The preparation method of described quinazoline compounds is:
a)There to be structure(I)Amino acid and structure(II)O-nitroacetophenone compound and palladium carbon catalysis Agent, disperse in a solvent;
b)To step a)Obtained mixture is 90-140o8-24h is reacted at a temperature of C, is obtained containing structure(III)'s Quinazoline compounds;
The R1For aryl when, described aryl is phenyl or naphthyl;
The R1For substituted aryl when, described substituted aryl be rubigan, p-methylphenyl, 3,4- dimethoxy benzenes Base, p-methoxyphenyl, m-methoxyphenyl, o-methoxyphenyl, p-trifluoromethyl phenyl, to tert-butyl-phenyl, to fluorobenzene Base, to Ethyl formate phenyl or p-bromophenyl;
The R1For alkyl when, described R1For methyl, n-propyl, the tert-butyl group or cyclohexyl;
The R2For fluorine, chlorine or methyl;
The R3For aryl when, phenyl can be divided.
The R3For substituted aryl when, described substituted aryl be p-fluorophenyl, p-bromophenyl, rubigan, to methyl Phenyl;
The R3For alkyl when, described alkyl is the tert-butyl group, cyclopenta or n-hexadecyl;
The catalyst is commercially available various palladium carbons(Pd/C);
The mol ratio of the o-nitroacetophenone compound and amino acid is 1:1—1:3;
The mol ratio of the o-nitroacetophenone compound and palladium carbon is 20:1—200:1;
The solvent of the reaction is acetonitrile, toluene, N,N-dimethylformamide, dimethyl sulfoxide, dioxane or water;
Described reaction temperature is 90-140oC;
The described reaction time is 8-24h.
Positive beneficial effect:Compared with existing the field of chemical synthesis correlation technique, the present invention is realized with adjacent nitre for the first time Benzoylformaldoxime class compound and Amino acid synthesis quinazoline compounds and preparation method thereof, in the method, it is not necessary to add and appoint What oxidant, reducing agent, part and alkalinity additive, and reaction condition is gentle, can have to water and air fine Compatibility, it is easy to accomplish large-scale production.Test result indicates that the yield of the quinazoline compounds of acquisition may be up to 92%.
Brief description of the drawings
Fig. 1 a are the nuclear magnetic resonance of the 4- methyl -2- phenylquinazolines prepared according to the embodiment of the present invention 1,2,3,4,5,6 Hydrogen is composed;
Fig. 1 b are the nuclear magnetic resonance of the 4- methyl -2- phenylquinazolines prepared according to the embodiment of the present invention 1,2,3,4,5,6 Carbon is composed;
Fig. 2 a are the 4- methyl -2- prepared according to the embodiment of the present invention 7(4- chlorphenyls)The hydrogen nuclear magnetic resonance of-quinazoline Spectrum.
Fig. 2 b are the 4- methyl -2- prepared according to the embodiment of the present invention 7(4- chlorphenyls)The nuclear magnetic resonance carbon of-quinazoline Spectrum;
Fig. 3 a are the proton nmr spectra of the 2- phenylquinazolines prepared according to the embodiment of the present invention 8;
The carbon-13 nmr spectra of 2- phenylquinazolines prepared by Fig. 3 b according to embodiments of the present invention 8;
Fig. 4 a are the 4- methyl -2- prepared according to the embodiment of the present invention 9(4- fluorophenyls)The hydrogen nuclear magnetic resonance of-quinazoline Spectrum;
Fig. 4 b are the 4- methyl -2- prepared according to the embodiment of the present invention 9(4- fluorophenyls)The nuclear magnetic resonance carbon of-quinazoline Spectrum;
Fig. 5 a are the proton nmr spectra of the 2,4- dimethyl quinazolines prepared according to the embodiment of the present invention 10;
Fig. 5 b are the carbon-13 nmr spectra of the 2,4- dimethyl quinazolines prepared according to the embodiment of the present invention 10;
Fig. 6 a are the proton nmr spectra of the 2,4- diphenyl quinazolines prepared according to the embodiment of the present invention 11;
Fig. 6 b are the carbon-13 nmr spectra of the 2,4- diphenyl quinazolines prepared according to the embodiment of the present invention 11;
Fig. 7 a are the proton nmr spectra of the 4,6- dimethyl -2- phenylquinazolines prepared according to the embodiment of the present invention 12;
Fig. 7 b are the carbon-13 nmr spectra of the 4,6- dimethyl -2- phenylquinazolines prepared according to the embodiment of the present invention 12.
Embodiment
Below in conjunction with the accompanying drawings and embodiment, the present invention is described further:
A kind of quinazoline compounds, its concrete structure formula are:
Wherein, R1For aryl, substituted aryl or alkyl;R2For fluorine, chlorine or methyl;R3For aryl, substituted aryl or alkyl.
A kind of preparation method of described quinazoline compounds, comprises the following steps:
a)There to be structure(I)Amino acid and structure(II)Catalytic action of the o-nitroacetophenone compound in palladium carbon Under, pass through agitating and heating in a solvent, you can obtain with structure(III)Quinazoline compounds of the invention:
Wherein, R1For aryl, substituted aryl or alkyl;R2For fluorine, chlorine or methyl;R3For aryl, substituted aryl or alkyl.
R1For aryl, described aryl is phenyl or naphthyl;Described R1For substituted aryl, described substituted aryl is pair It is chlorphenyl, p-methylphenyl, 3,4- Dimethoxyphenyls, p-methoxyphenyl, m-methoxyphenyl, o-methoxyphenyl, right Trifluoromethyl, to tert-butyl-phenyl, p-fluorophenyl, to Ethyl formate phenyl or p-bromophenyl;Described R1For alkyl, institute The alkyl stated is methyl, n-propyl, the tert-butyl group or cyclohexyl.
Described R2For fluorine, chlorine or methyl.
Described R3For aryl when, described aryl includes phenyl;Described R3For substituted aryl, described substituted aryl For p-fluorophenyl, p-bromophenyl, rubigan or p-methylphenyl;Described R3For alkyl, described alkyl include the tert-butyl group, Cyclopenta or n-hexadecyl.
The mol ratio of the o-nitroacetophenone compound and amino acid is 1:1—1:3.
The o-nitroacetophenone compound is 20 with palladium carbon mol ratio:1—200:1;The solvent of the reaction is second Nitrile, toluene, N,N-dimethylformamide, dimethyl sulfoxide, dioxane or water.
Described reaction temperature is 90oC—140oC。
The described reaction time is 8-24h.
Embodiment 1
In 10 milliliters of Schlenk reaction tubes of a clean dried, it is 10% Pd/C to sequentially add mass fraction 4.09 milligrams, 113 milligrams, 1 milliliter 40 milligrams of ortho-nitroacetophenone, phenylglycine toluene make solvent, load onto condensing reflux pipe, 130 under nitrogen protectionoC reacts 24 hours.After reaction terminates, by filtering, the catalyst of recovery, which can be circulated directly next time, to be made With a small amount of petroleum ether and ethyl acetate after being directly spin-dried for, filtrate(Volume ratio is 30:1)Dissolving, post is crossed by short silicagel column Separation, obtains 49.5 milligrams of white solids, yield 90%.
As shown in Figure 1a, carbon-13 nmr spectra is as shown in Figure 1 b for the proton nmr spectra of product manufactured in the present embodiment.From It has been confirmed that the product obtained is 4- methyl -2- phenylquinazolines in collection of illustrative plates.
Embodiment 2
In 10 milliliters of Schlenk reaction tubes of a clean dried, it is 10% Pd/C to sequentially add mass fraction 13.25 milligrams, 110 milligrams, 1 milliliter 40 milligrams of ortho-nitroacetophenone, phenylglycine toluene make solvent, load onto condensing reflux pipe, 120 under nitrogen protectionoC reacts 24 hours.After reaction terminates, by filtering, the catalyst of recovery, which can be circulated directly next time, to be made With a small amount of petroleum ether and ethyl acetate after being directly spin-dried for, filtrate(Volume ratio is 30:1)Dissolving, post is crossed by short silicagel column Separation, obtains 47 milligrams of white solids, yield 85%.
As shown in Figure 1a, carbon-13 nmr spectra is as shown in Figure 1 b for the proton nmr spectra of product manufactured in the present embodiment.From It has been confirmed that the product obtained is 4- methyl -2- phenylquinazolines in collection of illustrative plates.
Embodiment 3
In 10 milliliters of Schlenk reaction tubes of a clean dried, it is 10% Pd/C to sequentially add mass fraction 10.25 milligrams, 40 milligrams of ortho-nitroacetophenone, 113 milligrams, 1 milliliter water as solvent of phenylglycine, load onto condensing reflux pipe, nitrogen 100 under gas shieldedoC reacts 24 hours.After reaction terminates, by filtering, the catalyst of recovery can be recycled directly next time, Filtrate be directly spin-dried for after with a small amount of petroleum ether and ethyl acetate(Volume ratio is 30:1)Dissolving, post point is crossed by short silicagel column From obtaining 33 milligrams of white solids, yield 60%.
As shown in Figure 1a, carbon-13 nmr spectra is as shown in Figure 1 b for the proton nmr spectra of product manufactured in the present embodiment.From It has been confirmed that the product obtained is 4- methyl -2- phenylquinazolines in collection of illustrative plates.
Embodiment 4
In 10 milliliters of Schlenk reaction tubes of a clean dried, it is 10% Pd/C to sequentially add mass fraction 10.25 milligrams, 40 milligrams of ortho-nitroacetophenone, 98 milligrams, 1 milliliter water as solvent of phenylglycine, load onto condensing reflux pipe, nitrogen 140 under gas shieldedoC reacts 18 hours.After reaction terminates, by filtering, the catalyst of recovery can be recycled directly next time, Filtrate be directly spin-dried for after with a small amount of petroleum ether and ethyl acetate(Volume ratio is 30:1)Dissolving, post point is crossed by short silicagel column From obtaining 51 milligrams of white solids, yield 92%.
As shown in Figure 1a, carbon-13 nmr spectra is as shown in Figure 1 b for the proton nmr spectra of product manufactured in the present embodiment.From It has been confirmed that the product obtained is 4- methyl -2- phenylquinazolines in collection of illustrative plates.
Embodiment 5
In 10 milliliters of Schlenk reaction tubes of a clean dried, it is 10% Pd/C 5.5 to sequentially add mass fraction 120 milligrams, 1 milliliter milligram, 40 milligrams of ortho-nitroacetophenone, phenylglycine DMF make solvent, load onto condensing reflux pipe, and nitrogen is protected 120 under shieldoC reacts 24 hours.After reaction terminates, by filtering, the catalyst of recovery can be recycled directly next time, filtrate With a small amount of petroleum ether and ethyl acetate after being directly spin-dried for(Volume ratio is 30:1)Dissolving, crosses post separation by short silicagel column, obtains To 48 milligrams of white solids, yield 88%.
As shown in Figure 1a, carbon-13 nmr spectra is as shown in Figure 1 b for the proton nmr spectra of product manufactured in the present embodiment.From It has been confirmed that the product obtained is 4- methyl -2- phenylquinazolines in collection of illustrative plates.
Embodiment 6
In 10 milliliters of Schlenk reaction tubes of a clean dried, it is 10% Pd/C 6.0 to sequentially add mass fraction 110 milligrams, 1 milliliter milligram, 40 milligrams of ortho-nitroacetophenone, phenylglycine dioxane make solvent, load onto condensing reflux pipe, nitrogen 130 under gas shieldedoC reacts 10 hours.After reaction terminates, by filtering, the catalyst of recovery can be recycled directly next time, Filtrate be directly spin-dried for after with a small amount of petroleum ether and ethyl acetate(Volume ratio is 30:1)Dissolving, post point is crossed by short silicagel column From obtaining 46 milligrams of white solids, yield 84%.
As shown in Figure 1a, carbon-13 nmr spectra is as shown in Figure 1 b for the proton nmr spectra of product manufactured in the present embodiment.From It has been confirmed that the product obtained is 4- methyl -2- phenylquinazolines in collection of illustrative plates.
Embodiment 7
In 10 milliliters of Schlenk reaction tubes of a clean dried, it is 10% Pd/C to sequentially add mass fraction 4.05 milligrams, 140 milligrams, 1 milliliter 40 milligrams of ortho-nitroacetophenone, p-chlorophenylglycine dioxane make solvent, load onto condensation Return duct, 130 under nitrogen protectionoC reacts 10 hours.After reaction terminates, by filtering, the catalyst of recovery can be directly next Recycle, filtrate be directly spin-dried for after with a small amount of petroleum ether and ethyl acetate(Volume ratio is 30:1)Dissolving, passes through short silica gel Post crosses post separation, obtains 57 milligrams of white solids, yield 89%.
As shown in Figure 2 a, carbon-13 nmr spectra is as shown in Figure 2 b for the proton nmr spectra of product manufactured in the present embodiment.From It has been confirmed that the product obtained is 4- methyl -2- in collection of illustrative plates(4- chlorphenyls)- quinazoline.
Embodiment 8
In 10 milliliters of Schlenk reaction tubes of a clean dried, it is 10% Pd/C to sequentially add mass fraction 4.05 milligrams, 38 milligrams of o-nitrobenzaldehyde, 113 milligrams, 1 milliliter water as solvent of phenylglycine, load onto condensing reflux pipe, nitrogen 130 under gas shieldedoC reacts 18 hours.After reaction terminates, by filtering, the catalyst of recovery can be recycled directly next time, Filtrate be directly spin-dried for after with a small amount of petroleum ether and ethyl acetate(Volume ratio is 10:1)Dissolving, post point is crossed by short silicagel column From obtaining 31 milligrams of white solids, yield 60%.
As shown in Figure 3 a, carbon-13 nmr spectra is as shown in Figure 3 b for the proton nmr spectra of product manufactured in the present embodiment.From It has been confirmed that the product obtained is to 2- phenylquinazolines in collection of illustrative plates.
Embodiment 9
In 10 milliliters of Schlenk reaction tubes of a clean dried, it is 10% Pd/C 4.5 to sequentially add mass fraction Milligram, 40 milligrams of ortho-nitroacetophenone, to 113 milligrams, 1 milliliter water as solvent of fluorophenyl glycine, load onto condensing reflux pipe, nitrogen 130 under protectionoC reacts 12 hours.After reaction terminates, by filtering, the catalyst of recovery can be recycled directly next time, filter Liquid be directly spin-dried for after with a small amount of petroleum ether and ethyl acetate(Volume ratio is 25:1)Dissolving, post separation is crossed by short silicagel column, Obtain 53 milligrams of white solids, yield 89%.
As shown in fig. 4 a, carbon-13 nmr spectra is as shown in Figure 4 b for the proton nmr spectra of product manufactured in the present embodiment.From It has been confirmed that the product obtained is 4- methyl -2- in collection of illustrative plates(4- fluorophenyls)- quinazoline.
Embodiment 10
In 10 milliliters of Schlenk reaction tubes of a clean dried, it is 10% Pd/C 4.5 to sequentially add mass fraction 67 milligrams, 1 milliliter milligram, 40 milligrams of ortho-nitroacetophenone, the third glycine toluene make solvent, load onto condensing reflux pipe, and nitrogen is protected 140 under shieldoC reacts 24 hours.After reaction terminates, by filtering, the catalyst of recovery can be recycled directly next time, filtrate With a small amount of petroleum ether and ethyl acetate after being directly spin-dried for(Volume ratio is 3:1)Dissolving, crosses post separation by short silicagel column, obtains 24 milligrams of white solids, yield 62%.
As shown in Figure 5 a, carbon-13 nmr spectra is as shown in Figure 5 b for the proton nmr spectra of product manufactured in the present embodiment.From It has been confirmed that the product obtained is 2,4- dimethyl quinazolines in collection of illustrative plates.
Embodiment 11
In 10 milliliters of Schlenk reaction tubes of a clean dried, it is 10% Pd/C 4.5 to sequentially add mass fraction 113 milligrams, 1 milliliter milligram, 57 milligrams of adjacent nitro benzophenone, phenylglycine toluene make solvent, load onto condensing reflux pipe, nitrogen 140 under protectionoC reacts 18 hours.After reaction terminates, by filtering, the catalyst of recovery can be recycled directly next time, filter Liquid be directly spin-dried for after with a small amount of petroleum ether and ethyl acetate(Volume ratio is 40:1)Dissolving, post separation is crossed by short silicagel column, Obtain 55 milligrams of white solids, yield 78%.
As shown in Figure 6 a, carbon-13 nmr spectra is as shown in Figure 6 b for the proton nmr spectra of product manufactured in the present embodiment.From It has been confirmed that the product obtained is 2,4- diphenyl quinazolines in collection of illustrative plates.
Embodiment 12
In 10 milliliters of Schlenk reaction tubes of a clean dried, it is 10% Pd/C 4.5 to sequentially add mass fraction 113 milligrams, 1 milliliter milligram, 45 milligrams of 5- methyl -2- nitro-acetophenones, phenylglycine water as solvent, load onto condensing reflux pipe, 130 under nitrogen protectionoC reacts 20 hours.After reaction terminates, by filtering, the catalyst of recovery, which can be circulated directly next time, to be made With a small amount of petroleum ether and ethyl acetate after being directly spin-dried for, filtrate(Volume ratio is 40:1)Dissolving, post is crossed by short silicagel column Separation, obtains 54 milligrams of white solids, yield 90%.
As shown in Figure 7a, carbon-13 nmr spectra is as shown in Figure 7b for the proton nmr spectra of product manufactured in the present embodiment.From It has been confirmed that the product obtained is 4,6- dimethyl -2- phenylquinazolines in collection of illustrative plates.
In one embodiment, the preparation method of a kind of quinazoline compounds provided by the invention, wherein by adjacent nitre Benzoylformaldoxime class compound and amino acid, and catalyst palladium carbon, disperse in a solvent;By obtained reactant mixture by stirring Heating is mixed, obtains corresponding quinazoline compounds.
In the present invention, described amino acid is under the catalytic action of palladium carbon, can easily occur a depickling and Dehydrogenation reaction, generation reactive intermediate PdH2, the intermediate can be easy to ortho-nitroacetophenone being reduced into adjacent aminobenzene second Ketone, twice dehydration condensation reaction then occurs with the imines of generation again, generation intermediate product dihydroquinazoline, the intermediate product can Again under the catalytic action of palladium carbon through dehydrogenation oxidation, to generate last product quinazoline.It is adjacent in whole catalytic cycle Nitro-acetophenone is the acceptor of hydrogen, and amino acid is then hydrogen and the donor of carbon dioxide.The advantage of this method clearly, is not required to Want any oxidant, reducing agent, part and alkalinity additive, you can be smoothed out the reaction.
Above-mentioned is the explanation to the preferred embodiment of the invention, so that those skilled in the art can realize or use this hair Bright, some modifications to these embodiments are it will be apparent that as defined herein general for those skilled in the art Principle can be realized in other embodiments without departing from the scope or spirit of the present invention.Therefore, the scope of the invention is not Limited by above-mentioned specific embodiment.

Claims (6)

1. a kind of preparation method of quinazoline compounds, it is characterised in that its concrete structure formula is:
Wherein, R1For aryl, substituted aryl or alkyl;R2For fluorine, chlorine or methyl;R3For aryl, substituted aryl or alkyl;
The preparation method of described quinazoline compounds, comprises the following steps:
a)There to be structure(I)Amino acid and structure(II)O-nitroacetophenone compound under the catalytic action of palladium carbon, Pass through agitating and heating in a solvent, you can obtain with structure(III)Quinazoline compounds of the invention:
Wherein, R1For aryl, substituted aryl or alkyl;R2For fluorine, chlorine or methyl;R3For aryl, substituted aryl or alkyl;
Described R1For aryl when, described aryl is phenyl or naphthyl;
Described R1For substituted aryl when, described substituted aryl be rubigan, p-methylphenyl, 3,4- Dimethoxyphenyls, P-methoxyphenyl, m-methoxyphenyl, o-methoxyphenyl, p-trifluoromethyl phenyl, to tert-butyl-phenyl, p-fluorophenyl, To Ethyl formate phenyl or p-bromophenyl;Described R1For alkyl when, described alkyl is methyl, n-propyl, the tert-butyl group or ring Hexyl;
Described R3For aryl when, described aryl is phenyl;Described R3For substituted aryl when, described substituted aryl for pair Fluorophenyl, p-bromophenyl, rubigan or p-methylphenyl;Described R3For alkyl when, described alkyl be the tert-butyl group, ring penta Base or n-hexadecyl.
A kind of 2. preparation method of quinazoline compounds according to claim 1, it is characterised in that:The ortho-nitrophenyl The mol ratio of second ketone compounds and amino acid is 1:1—1:3.
A kind of 3. preparation method of quinazoline compounds according to claim 1, it is characterised in that:The ortho-nitrophenyl Second ketone compounds are 20 with palladium carbon mol ratio:1—200:1.
A kind of 4. preparation method of quinazoline compounds according to claim 1, it is characterised in that:The reaction it is molten Agent is acetonitrile, toluene, N,N-dimethylformamide, dimethyl sulfoxide, dioxane or water.
A kind of 5. preparation method of quinazoline compounds according to claim 1, it is characterised in that:Described reaction temperature Spend for 90oC—140oC。
A kind of 6. preparation method of quinazoline compounds according to claim 1, it is characterised in that:During described reaction Between be 8-24h.
CN201510957056.0A 2015-12-21 2015-12-21 A kind of quinazoline compounds and preparation method thereof Expired - Fee Related CN105418516B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510957056.0A CN105418516B (en) 2015-12-21 2015-12-21 A kind of quinazoline compounds and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510957056.0A CN105418516B (en) 2015-12-21 2015-12-21 A kind of quinazoline compounds and preparation method thereof

Publications (2)

Publication Number Publication Date
CN105418516A CN105418516A (en) 2016-03-23
CN105418516B true CN105418516B (en) 2018-03-02

Family

ID=55497121

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510957056.0A Expired - Fee Related CN105418516B (en) 2015-12-21 2015-12-21 A kind of quinazoline compounds and preparation method thereof

Country Status (1)

Country Link
CN (1) CN105418516B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108976173B (en) * 2016-12-30 2022-01-18 江西师范大学 Preparation method of 4-aryl-2- (2- (sulfur trifluoromethyl) aryl) quinazoline
CN111620824B (en) * 2020-06-24 2023-08-22 武汉理工大学 Method for synthesizing quinazoline compound by taking aromatic aldehyde as substrate
CN112125900B (en) * 2020-09-29 2022-11-18 常州工程职业技术学院 Synthetic method of isoquinolino-quinazolinone compound

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102675222A (en) * 2012-04-28 2012-09-19 清华大学 Method for preparing multi-substituted quinazoline and heterocyclic pyrimidine derivative
CN102675223A (en) * 2012-04-28 2012-09-19 清华大学 Preparation method for polysubstitution quinazoline and heterocyclic ring pyrimidine derivative
CN105327703A (en) * 2014-08-08 2016-02-17 中国科学技术大学 Preparation method for gold nanometer catalyst, and obtained catalyst product and application thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102675222A (en) * 2012-04-28 2012-09-19 清华大学 Method for preparing multi-substituted quinazoline and heterocyclic pyrimidine derivative
CN102675223A (en) * 2012-04-28 2012-09-19 清华大学 Preparation method for polysubstitution quinazoline and heterocyclic ring pyrimidine derivative
CN105327703A (en) * 2014-08-08 2016-02-17 中国科学技术大学 Preparation method for gold nanometer catalyst, and obtained catalyst product and application thereof

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
Copper-catalyzed three-component one-pot synthesis of quinazolines;Jia Ju,等;《Tetrahedron》;20120914;第68卷;全文 *
Palladium-catalyzed one pot 2-arylquinazoline formation via hydrogen-transfer strategy;Huamin Wang,等;《Org. Biomol. Chem.》;20140806;第12卷(第39期);全文 *
Simple and straight forward synthesis of 2,4‐disubstituted quinazolines in aqueous medium;Madhav Bandaru,等;《European Journal of Chemistry》;20120630;第3卷(第2期);全文 *
Supported gold-catalyzed and ammonia-promoted selective synthesis of quinazolines in aqueous media;Wang Zhiyong,等;《Org. Chem. Front.》;20141215;第2卷(第2期);全文,尤其表2 *

Also Published As

Publication number Publication date
CN105418516A (en) 2016-03-23

Similar Documents

Publication Publication Date Title
Ma et al. Homochiral covalent organic frameworks for asymmetric catalysis
CN105418516B (en) A kind of quinazoline compounds and preparation method thereof
Li et al. Redox Chemistry between Europium (III) Amide and Pyrrolyl-Functionalized Secondary Amines. Synthesis and Structural Characterization of Lithium and Novel Lanthanide Complexes Incorporating Functionalized Pyrrolyl Ligands
CN109400564A (en) A kind of 4-chromanone class compound and preparation method thereof containing trifluoromethyl
CN105777662B (en) A kind of benzoxazole and benzimidazoles compound preparation method
CN102228840A (en) Preparation method of load type Fe2O3 catalyst and method for synthesizing dimethyl carbonate (DMC) by using load type Fe2O3 catalyst
Mambrini et al. Memory of Chirality in a Flow‐Based System: Enantioselective Synthesis of Quaternary α‐Amino Acids Using Flow Microreactors
CN105503513B (en) The method of silicon dioxide carried catalysis of phosphotungstic acid synthesis 4,4 '-dichloromethyl biphenyl
An et al. Synthesis of 2‐Phosphoryl‐3‐Monofluorovinylindoles under Catalyst‐and Additive‐Free Conditions
CN110903319B (en) Preparation method of 2-phosphonothioflavonoid compound
CN104292247B (en) A kind of have mixed ligand containing cadmium two-dimensional polymer and preparation method thereof
CN104945342A (en) Nitrogen heterocyclic carboxylate ligand and preparation method thereof
CN106432103A (en) Quinazolinone compounds and preparation method thereof
CN107298683B (en) A kind of synthetic method of chirality benzodiazepine * compound
CN109851544A (en) A kind of preparation method of polysubstituted pyrrole compound
CN109928893A (en) A kind of α-Process for the cyanation of N- arylmethyl aniline
CN103880708A (en) Improved catalytic synthesis method of malononitrile
CN103304443B (en) Method for catalyzing and condensing aromatic aldehyde and active methylene compound by using multi-amino ionic liquid
CN103467390A (en) Method for preparing 2-amino-4(3H)-quinazolinones
Mao et al. Titanium-mediated reductive cross-coupling reactions of imines with terminal alkynes: An efficient route for the synthesis of stereodefined allylic amines
CN102166530A (en) Bi-chiral organic small molecular catalyst and preparation method thereof
Métro et al. Highly Enantioselective Synthesis of Linear β‐Amino Alcohols
CN105294532B (en) A kind of preparation method of L hydroxy-prolines
CN104326861A (en) Preparation method of 1,3-diene derivatives having aggregation-induced emission property
CN102241590B (en) Synthetic method of spirocyclic tetronic acid compound key intermediate

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
CB03 Change of inventor or designer information
CB03 Change of inventor or designer information

Inventor after: Tang Lin

Inventor after: Tang Wenbin

Inventor after: Tan Meirong

Inventor after: Yang Die

Inventor before: Tang Lin

GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20180302

Termination date: 20191221